August 29, 2016
A New Jersey federal judge has ruled that Otsuka Pharmaceutical Co. Ltd. can't duck antitrust counterclaims by generics maker Apotex Corp. in an infringement suit over patents related to the antipsychotic drug Abilify, but agreed to split the case and hear the infringement claims first.